Clinical Trial Update: A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating ACI-7104.056 in early-stage Parkinson's disease; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Parkinson Disease
• Parkinson Disease

Drugs mentioned

• ACI-7104.056

Snippet

Sponsor: AC Immune SA | Conditions: Parkinson Disease, Parkinson Disease 6, Early-Onset | Phase 2 | Status: ACTIVE_NOT_RECRUITING